Introduction:
Narcolepsy-cataplexy (NC) is a disabling life-long sleep-wake disorder, characterized by excessive daytime sleepiness (EDS) and sudden loss of muscle tone triggered by emotions (cataplexy) [1] . Accessory symptoms include sleep paralysis, hypnagogic hallucinations and fragmented nighttime sleep. Cataplexy is specific for narcolepsy and its presence allows diagnosing NC on clinical grounds. Sleep studies in NC, in particular the occurrence of two or more sleep onset REM periods (SOREMPs) in the multiple sleep latency test (MSLT) is characteristic though not specific for NC [2] . Two biological markers are tightly associated with cataplexy: there is a strong association to the human leukocyte antigen system (HLA) and a loss of the hypothalamic neuropeptide hypocretin (also called orexin) in the cerebrospinal fluid (CSF). The genetic marker HLA DQB1*0602 is found in 98% of narcolepsy patients with cataplexy compared to 35% of healthy controls [3] . CSF hypocretin levels <110pg/ml are considered low or undetectable and are diagnostic for narcolepsy, between 110 -200pg/ml intermediate and levels >200 pg/ml are considered normal [4] .
Treatment is symptomatic and includes stimulant drugs (amphetamine analogs and modafinil) targeting EDS and antidepressants or sodium oxybate to treat cataplexy. Amphetamine analogs enhance adrenergic and dopaminergic transmission by blocking reuptake and stimulating release at the presynaptic terminals [5, 6] . Modafinil's mechanism of action is complex and distinct from other wakefulness-promoting drugs. It modulates glutamate, GABA, histamine and hypocretin, and to the lesser extent the monoaminergic systems [7] . It has been shown, that dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil [8] . The anticataplectic effect of antidepressants is associated mainly with adrenergic uptake inhibition, while serotonergic uptake blockers are less effective [9] . Sodium oxybate may act on GABA B receptors or its own receptors and may also modulate dopaminergic neurotransmission [10] .
Hypocretin is involved in various basic functions such as sleep-wake regulation, feeding, reward and drug-seeking behavior. Dopaminergic system is essential for motor control but it also promotes wakefulness and plays an essential role in reward processing and in male sexual response [11, 12] . The use of dopamine agonists can lead to hypersexuality [13] . The two systems are tightly interconnected. Hypocretin efferents from the lateral hypothalamus innervate midbrain dopaminergic nuclei, and dopamine cell bodies express hypocretin receptors [14, 15] . Activation of hypocretin-containing neurons in the ventral tegmental area (VTA) leads to the direct activation of mesolimbic dopamine neurons and is probably associated with the development of rewarding effects [16] . Dopamine itself modulates the firing of hypocretin neurons. A dose-dependent dual feedback mechanism between the two systems is suggested where D1-and D2-like receptors have opposing effects on the excitatory presynaptic terminals impinging onto hypocretin/orexin neurons [17] .
In NC the loss of CSF hypocretin is tightly associated with cataplexy, and strong emotions.
Positive emotions (such as laughing, joking and elation) are typical triggers of cataplexy suggesting a role of hypocretins in emotional motor control. Sexual excitement and orgasm are also associated with strong positive emotions. Complete loss of muscle tone during sexual intercourse was first described in a single case report of a male narcolepsy patient in 1928 by Rothfeld [18] . He named the phenomenon orgasmolepsy. A year later Levin reported a case with partial cataplexy in a male narcolepsy patient during sexual intercourse and masturbation [19] . Since then loss of muscle tone during sexual intercourse has been rarely reported in the literature [20] [21] [22] but without any detailed description of its characteristics. It has also been suggested recently that hypocretins are involved in male sexual behavior in rats [23, 24] .
Local application of hypocretin in the medial preoptic area increased sexual arousal and copulatory performance [23] while systemic hypocretin blockade resulted in impaired copulatory behavior. In addition, hypocretins dose-dependently increased neuron firing in the ventral tegmental area [24] , an area which is known to be involved in sexual behavior. The human "sexual response cycle" consists of four sequential phases: sexual excitement, plateau, orgasm, and resolution. Each phase of the sexual cycle has its own neural substrate as assessed by PET [25] [26] [27] [28] and fMRI [29, 30] studies. Distinct activation patterns have been observed during onset and maintenance of sexual arousal in various brain regions including the amygdala, hippocampus, hypothalamus, insular and cingulate cortex, putamen, the cortical regions. These regions are known to be targeted also by the hypocretins.
Cataplexy-like symptoms have also been reported by non narcoleptic subjects, more often in hypersomnolent patients then in healthy controls [31] . Similarly, orgasmolepsy has also been reported in patients with various sleep disorders (mainly sleep apnea) [21] but not in healthy controls.
The aim of the present study was to assess the frequency of and to obtain detailed clinical information on loss of muscle tone during sexual intercourse (orgasmolepsy) in a series of NC-patients, in patients with EDS/fatigue due to various sleep disorders and in healthy controls.
Patients and methods:

Different questionnaires (including the Sleep Questionnaire and the Stanford Cataplexy
Questionnaire [21] ) completed by 77 adults (29 with NC (11 male), 28 with different sleep disorders and excessive daytime sleepiness (EDS) or/and fatigue (19 male) and 20 healthy controls (9 male) were reviewed. The sleep questionnaire includes 69 questions addressing sleep-wake habits and complaints. The answers provide information on symptoms/signs suggestive of sleep apnea (SA), EDS, narcolepsy, different parasomnias, insomnia and disturbances of the sleep-wake rhythm. Possible answers include "yes" and "no" or provide a rating on a 5 point scale depending on the frequency of occurrence ("almost always", "often", "occasionally", "seldom" or "never". Four validated scores are included in the questionnaire.
The Epworth Sleepiness Scale (ESS), a scale for assessment of subjective EDS based on eight questions on the urge to sleep in various life situations [32] . Each question is rated on a 4 point scale ranging from 0 to 3 points, thus resulting in a maximum sum score of 24 points. A cut-off score of 10 is considered abnormal. The Sleep Apnea Scale of the Sleep Disorders Questionnaire (SA-SDQ) is a screening instrument for obstructive sleep apnea. The SA-SDQ consists of 12-items for sleep-related breathing disorders and includes the well-known risk factors of age and body mass index (BMI). Cut-off scores of 32 for women and 36 for men (range is 12-60) provided a sensitivity of 85% and a specificity of 72% for males and 88% and 81% for females, respectively [33] . The 11-item Ullanlinna Narcolepsy Scale (UNS) is a widely used screening instrument for narcolepsy [34] . A cut-off of 14 has been shown to have a high sensitivity (100-96%) but a variable specificity (99-56%) for patients with narcolepsycataplexy [31, 33] . The Swiss narcolepsy score (SNS) is based on five questions, a score <0 had a sensitivity and specificity for narcolepsy of 96 and 98% respectively [31] . The Stanford cataplexy questionnaire contains 51 items on cataplexy, including questions pertaining to cataplexy triggers, localization, duration and frequency of the attacks [21] . The subjects who reported on orgasmolepsy were contacted to obtain more details about their complaints.
The available clinical data included neurological examination, overnight videopolysomnography (PSG) and multiple sleep latency test (MSLT), treatment was also documented. Hypocretin CSF levels were available in 28 patients (of them 21 with NC) and HLA DQB1* 0602 in 47 patients (29 of whom had NC). The diagnoses of the patients with sleep disorders included: behaviorally induced insufficient sleep syndrome (BIISS) n=13, EDS of unknown origin n=3, narcolepsy-like features n=3, monosymptomatic narcolepsy (i.e. without cataplexy) n=2, depression and hypersomnia n=2, other n=5.
All narcolpepsy patients and all control subjects were a part of a large study on narcolepsy including cataplexy and its characteristics. The study was approved by the local ethics committee and written informed concent was obtained from all subjects. The patients with sleep disorders other then narcolepsy were retrospectively analyzed from the pool of our sleep laboratory. Before filling in our questionnaires they signed an informed concent, that the data obtained during their clinical examinations can be used for research purposes at a later stage.
Main outcome measures:
Cataplexy and cataplexy-like episodes during sexual intercourse (orgasmolepsy).
Results:
Loss of muscle tone during sexual intercourse was reported by three NC patients (two female, one male), and by one patient with BIISS, but by none of the healthy controls. Four NC patients and three patients with sleep disorders were uncertain about the occurrence of muscle weakness during sexual intercourse. Table 1 .
We were able to contact the three NC patients, reporting orgasmolepsy and obtain a detailed description of their complaints. MSLT documented two SOREM episodes and shortened mean sleep latency of 1.6 minutes.
He was negative for HLA DQB1* 0602 and had normal CSF hypocretin level (417pg/ml).
Actigraphy showed poor sleep hygiene (as defined by late, irregular and highly variable (>3h) bed and wake-up times) and BIISS, which was retained as most likely diagnosis. On Stanford cataplexy questionnaire he reported cataplexy-like symptoms with a frequency of 3-4/week including muscle weakness in one or both legs or arms, dropping things from his hands and blurred speech when being angry, worried, frightened, during and after sports activities and in romantic situations as well as during sexual intercourse. During these episodes he was not sure whether he could hear and whether he was awake or asleep. He did not appear for his planned visits at the outpatient clinic and could not be contacted for further details
Discussion:
Orgasmolepsy is a disturbing and highly embarrassing symptom reported by 10% (3/29) of our series of NC patients. This frequency is slightly lower compared to the scarce data in the literature, 22-31% in two earlier studies from Stanford (40/130 and 13/58 respectively) [20, 21] and similar to that found in a German study, 11% (5/47) [22] . A detailed description of orgasmolepsy and its relationship to other cataplexy features could be obtained in three NC patients. They all had frequent partial cataplexy (1/week to 3-4/day) but only one patient reported frequent generalized cataplexy with falls. Cataplexy triggers were mainly strong positive emotions, laughter being the most common. EDS was severe in all of them (resp. ESS 17, 18 and 19) . The two female patients also experienced sleep paralysis and hallucinations. In one patient sodium oxybate proved efficient for all REM-sleep dysregulation symptoms with remarkable effect on cataplexy and orgasmolepsy, but only mild effect on sleepiness.
Orgasmolepsy was reported also by a patient with BIISS with EDS and cataplexy-like symptoms. Although we could not follow up this patient for further details, these findings confirm that both cataplexy-like symptoms and orgasmolepsy may occur also in nonnarcoleptic subjects with other sleep disorders (mainly sleep apnea [21] ) and , rarely, even normal controls. A higher frequency of these episodes in hypersomnolent patients [31] suggests that EDS and insufficient arousal may serve as a gating mechanism for the occurrence of cataplexy-like symptoms including orgasmolepsy [35] . Thus a sexual medicine specialist may encounter orgasmolepsy as a manifestation of cataplexy not only in NC patients but also in patients with EDS of different origin. In NC patients anticataplectic drugs (antidepressants or sodium oxybate) should be effective also for orgasmolepsy. In sleepy patients EDS should be addressed depending on its cause. For example in sleep apnea patients continuous positive airway pressure (CPAP) treatment should be initiated, in patients with BIISS behavioral measures with optimizing the sleep hygiene (regular bed and wake-up times, sufficient duration of the nighttime sleep) should be discussed.
In the male NC patient orgasmolepsy only occurred with a partner in a relationship with emotional commitment and trust. Similar, both female patients experienced orgasmolepsy with their partners living in a stable partnership. Differential neural activation of various brain regions in men and women has been observed in response to visual sexual stimuli [22] but not during orgasm [36] . Therefore, the sexually differentiated neural activity during sexual arousal that precedes orgasm is more likely to reflect the cognitive processing of sexual stimuli, such as motivation and desire, rather than physiological arousal [37] . Both sexes experienced orgasmolepsy with their partners living in a stable partnership suggesting that emotional disinhibiton and diminished self control requires a state of intimacy as a prerequisite for orgasmolepsy. Deactivation in the prefrontal cortex, an area responsible for self-control, has been reported during sexual arousal and orgasm, suggesting the presence of emotional disinhibiton [26, 27] . Amygdala deactivation has been observed during various euphoric states, including orgasm and sexual arousal [25] , cocaine rush [38] and when volunteers reportedly deeply in love viewed pictures of their loved ones [39] . Hence amygdala deactivation has been proposed to be responsible for euphoric states. On the other hand, structural and functional amygdala abnormalities in NC have been reported in both animals [40] and humans [41] . A recent fMRI study found an exaggerated amygdala response to humor and dysfunctional amygdala-hypothalamic interaction in hypocretin deficient narcolepsy patients with cataplexy [42] . In narcoleptic dogs cataplexy-related neuron populations in the amygdala are thought to mediate cataplexy via interactions with mesopontine regions controlling atonia [40] . We therefore hypothesize that orgasmolepsy may be related to persisting amygdala firing during sexual intercourse and consequent disinhibition of pontine and medullar atonia-generating neurons. Considering the existence of dense hypocretinergic projections to the medial preoptic area, the bed nucleus of stria terminalis and the ventral tegmental area [14] , known to be part of reward networks including the ones involved in sexual arousal and orgasm, a role for hypocretin in orgasmolepsy can be suggested. Hypocretin deficiency and impaired reward processing in patients with NC may facilitate the occurrence of orgasmolepsy.
Conclusion:
Cataplexy during sexual intercourse is a distinct feature in NC patients. Less commonly orgasmolepsy-is reported also by patients with excessive daytime sleepiness of other origin.
Thus a sexual medicine specialist may encounter orgasmolepsy not only as a manifestation of cataplexy in NC patients but also in patients with EDS of different origin. Treatment options in narcolepsy include anticataplectic drugs and in EDS depend on its cause.
Insufficient arousal may serve as gating mechanism for cataplexy and cataplexy-like symptoms, including orgasmolepsy. Hypocretin deficiency and reward dysregulation in narcolepsy may facilitate the phenomenon and contribute to its repetitive occurrence.
